Modelling the flow of patients across different states (treated,
untreated, lapsed etc.) normally requires sophisticated standalone software. This causes problems because forecasts are no longer in a familiar Excel format. Data can be trapped within the stand-alone, black-box systems model. Spreadsheets can no longer be transferred between users.
In the past, flow modelling could only be accomplished with complex stand-alone software. This is no longer true, as powerful flow modelling functionality can now be dropped into your spreadsheet models with FlexiCast, which includes pre-built flow models and flow-modelling tools to help make sense of your real-world data.
Pre-built, stress-tested flow model tools within FlexiCast
"FlexiCast is a great tool as it is based on evidence. This makes it a lot easier to sell forecasting results to top level decision makers."
Strategy and Portfolio Manager, Top-10 pharmaceutical company
FlexiCast is Inpharmation’s evidence-based pharma forecasting software, developed specifically for the challenges faced by pharmaceutical forecasting, business development and marketing teams. Inpharmation has been delivering evidence-based forecasts to the pharmaceutical industry for two decades and FlexiCast distills the evidence-based forecast principles that we’ve developed into a flexible and easy-to-use forecast platform.
FlexiCast is designed from the ground-up to flexibly fit into your forecast workflow. When you purchase FlexiCast you gain access to the following:
- 73 demand forecast models and tools that have been developed specifically for pharma forecasts.
- Pharma-validated peak share models that can reduce your forecast error by up to 75%*.
- Pharma-Specific™ combined forecast approaches that can reduce forecast error up to 70%**.
*Taking a combined approach vs. a standard dilution model approach. **Based on a combination of extrapolation methods vs. an uncombined random-walk approach.
The evidence behind Inpharmation’s fact-based approach to pricing is meticulously documented in the book Sales Forecasting for Pharmaceuticals: An Evidence-Based Approach by Inpharmation’s Managing Director, Gary Johnson.